Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:01 pm Sale | 2024-09-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | ARMISTICE CAPITAL LLC | 0 0.000% | -5,200,000 (Position Closed) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 8,359,768 9.900% | 1,251,671 (+17.61%) | Filing History |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BRAIDWELL LP | 2,385,623 2.920% | -2,213,861 (-48.13%) | Filing History |
| 2024-02-14 2:26 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | ARMISTICE CAPITAL LLC | 5,200,000 6.490% | 28,000 (+0.54%) | Filing History |
| 2024-02-13 5:02 pm Sale | 2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Vanguard Group Inc | 4,401,636 5.490% | -343,685 (-7.24%) | Filing History |
| 2024-02-12 5:32 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | James E. Flynn | 5,788,024 7.190% | 1,160,714 (+25.08%) | Filing History |
| 2024-02-09 4:30 pm Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Brightstar Associates LLC | 23,059,708 28.200% | -48,136 (-0.21%) | Filing History |
| 2024-02-06 4:52 pm Sale | 2023-12-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | GOLDMAN SACHS GROUP INC GS | 2,007,447 2.500% | -1,828,712 (-47.67%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 5,976,266 7.500% | 556,241 (+10.26%) | Filing History |
| 2024-01-23 09:45 am Sale | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | STATE STREET CORP STT | 2,470,813 3.080% | -977,211 (-28.34%) | Filing History |
| 2023-03-22 4:17 pm Purchase | 2023-03-13 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | James E. Flynn | 4,627,310 6.090% | 2,278,082 (+96.97%) | Filing History |
| 2023-02-14 4:19 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group LLC | 7,108,097 9.900% | 1,427,180 (+25.12%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BRAIDWELL LP | 4,599,484 6.680% | 4,599,484 (New Position) | Filing History |
| 2023-02-14 12:32 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | ARMISTICE CAPITAL LLC | 5,172,000 7.650% | 1,741,846 (+50.78%) | Filing History |
| 2023-02-14 09:12 am Sale | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BANK OF AMERICA CORP BAC | 302,410 0.400% | -2,722,903 (-90.00%) | Filing History |
| 2023-02-10 09:42 am Sale | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | James E. Flynn | 2,349,228 3.480% | -3,231,228 (-57.90%) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Vanguard Group Inc | 4,745,321 7.020% | 1,276,004 (+36.78%) | Filing History |
| 2023-02-08 4:16 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Brightstar Associates LLC | 23,107,844 28.200% | 6,535,474 (+39.44%) | Filing History |
| 2023-02-08 09:52 am Purchase | 2022-12-30 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | GOLDMAN SACHS GROUP INC GS | 3,836,159 5.700% | 212,914 (+5.88%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | BlackRock Inc. BLK | 5,420,025 8.000% | 1,622,456 (+42.72%) | Filing History |